- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT02382705
SB3 Battery Life Observational Study
Clinical Impact of Longer Battery Life on Small Bowel Capsule Endoscopy: a Prospective Observational Study
Capsule endoscopy (CE) is a non-invasive means of visualizing the small bowel. Common indications for CE include obscure gastrointestinal (GI) bleeding, inflammatory bowel disease like crohn's disease or ulcerative colitis, celiac disease, and polyposis syndrome.
While CE has high diagnostic value for small bowel lesions, a significant limitation of this technology is the finite battery life which results in incomplete examination of the small bowel approximately 16.5% of the time. Numerous attempts of using pharmacological (e.g. prokinetics, purgatives) as well as non-pharmacological measures (e.g. real-time viewer, chewing gum) to improve completion rates, defined by entry of CE into the cecum, led to mixed results. Currently routine use of prokinetics (agents that speeds up gut motility) is not recommended.
This study aims to determine whether longer battery of the newer generation capsule endoscopy system improves study completion rate and diagnostic yield.
Studieöversikt
Status
Betingelser
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
British Columbia
-
Vancouver, British Columbia, Kanada, V6Z 2K5
- St. Paul's Hospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- Male or female age 19 or greater who are referred for small bowel capsule endoscopy
- Willing and able to provide written informed consent
Exclusion Criteria:
- Unwillingness or inability to swallow pill
- Known or suspected obstruction or bowel stricture
- Endoscopic placement of capsule camera
- Concomitant enrollment in a prospective study in the treatment arm receiving prokinetics for the purpose of enhancing bowel motility. (i.e. control arm not receiving any motility-enhancing agent can be included)
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: Kohort
- Tidsperspektiv: Blivande
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Completion Rate (Rate at Which Small Bowel is Completely Examined)
Tidsram: 0.1 - 12 hours
|
rate at which small bowel is completely examined (capsule endoscopy enters cecum)
|
0.1 - 12 hours
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Diagnostic Yield
Tidsram: 0.1 - 12 hours
|
rate at which a pathological finding is identified on capsule endoscopy
|
0.1 - 12 hours
|
Gastric Transit Time
Tidsram: 0.1 - 12 hours
|
time it takes for capsule camera to traverse the stomach
|
0.1 - 12 hours
|
Small Bowel Transit Time
Tidsram: 0.1 - 12 hours
|
times it takes for capsule camera to traverse the entire small bowel.
|
0.1 - 12 hours
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Robert Enns, MD, University of British Columbia
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- H14-03253
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .